At a glance
ClinicalIndex Comparison RecordN/ACompleted· 197 enrolled
Drug / intervention
Ness L300 +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Functional Ambulation: Standard Treatment vs. Electronic Stimulation Therapy (FASTEST)Trial in Chronic Post-Stroke Subjects With Foot Drop
In Brief
A clinical study evaluating Ness L300 and Ankle-foot orthosis for Sensorimotor Gait Disorder and 4 related conditions. Completed, enrolled 197 participants across 11 sites.
Detailed Summary
The objective of this study is to determine the effectiveness of the NESS L300 (L300) in improving gait parameters, function, and quality of life among stroke subjects (greater than or equal to 3 months post stroke)with drop foot.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSensorimotor Gait Disorder, Neurologic Ambulation Disorder, Gait, Drop Foot, Poststroke Hemiparesis, Post-Cerebrovascular Accident (CVA) Hemiparesis
CountriesUnited States
CollaboratorsMedidata Solutions, University of Cincinnati
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2010
First PostedJun 2010
Primary CompletionDec 2012
Study CompletionFeb 2013
TodayJul 2026
First PostedJun 8, 2010
Enrollment StartMay 1, 2010
Primary CompletionDec 1, 2012
Study CompletionFeb 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 16.1 years ago
Interventions
Ness L300device
The Ness L300 delivers functional electrical stimulation (FES), which improves gait function, stroke-specific quality of life, functionality, and safety for persons with stroke.
Ankle-foot orthosisdevice
The Control Group will walk with a "usual" ankle-foot orthosis (AFO).